ScienceDex / Researcher record
Donghoon Chung
- University of Minnesota · Pharmacology (NIH department code)
- University of Louisville · Microbiology & Immunology (NIH department code)
- University of Louisville (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #213
- Top 5% Funded
- R01 Holder
- Translational
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2025 | $684,921 | 2 | #23,929 |
| 2026 | $18,509,748 | 5 | #213 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20252 records
- FY2026 · selected5 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9658299Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pharmacology
- Microbiology & Immunology
FY2026 award records by amount
NIH award records listing Donghoon Chung as a PI. Multi-PI records show the full award amount for context.
- 4U19AI171954-02U19Contact PIMidwest AViDD CenterUniversity of Minnesota · Pharmacology (NIH department code)$17Maward amount
- 1R01AI195717-01R01Contact PIOptimization of a novel and effective antiviral agent targeting Zika NS4BUniversity of Louisville · Microbiology & Immunology (NIH department code)$627.6Kaward amount
- 5R01AI187483-02R01Contact PIDevelopment of novel antivirals for arthritogenic alphavirusesUniversity of Louisville · Microbiology & Immunology (NIH department code)$597.5Kaward amount
- 3R01AI195717-01S1R01Contact PIOptimization of a novel and effective antiviral agent targeting Zika NS4B$139.9Kaward amount
- 3R01AI187483-02S1R01Contact PIDevelopment of novel antivirals for arthritogenic alphavirusesUniversity of Louisville · Microbiology & Immunology (NIH department code)$133.9Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Donghoon Chung as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardUniversity of Minnesota
- 2025$500K Cumulative Funding
- 2025R01 Grant Holder
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026$5M Cumulative Funding
- 2026$10M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #213
- 2026Entered Top 25% NationallyRanked #213
- 2026Entered Top 10% NationallyRanked #213
- 2026Entered Top 5% NationallyRanked #213
- 2026Multi-Institutional ResearchAwards at 2 institutions
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Donghoon Chung.
Dahai Luo
University of Louisville
6
shared awards
Thomas D Bannister
University of Louisville
6
shared awards
Fang Li
University of Minnesota
1
shared award
Lanying Du
University of Minnesota
1
shared award
Louis Daniel Scampavia
University of Minnesota
1
shared award
Ming Luo
University of Minnesota
1
shared award
Reuben S Harris
University of Minnesota
1
shared award
Rommie E Amaro
University of Minnesota
1
shared award
Ryan Langlois
University of Minnesota
1
shared award
Thomas D Bannister
University of Minnesota
1
shared award